DOCSLIB.ORG

Report Profundo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Report Profundo Eerlijke Verzekeringswijzer Dutch Fair Insurance Guide A Case Study on Transparency & Accountability A research paper for Amnesty International, Dierenbescherming, FNV, Milieudefensie, Oxfam Novib and PAX Eerlijke Verzekeringswijzer Dutch Fair Insurance Guide A Case Study on Transparency & Accountability A research paper for Amnesty International, Dierenbescherming, FNV, Milieudefensie, Oxfam Novib and PAX Date of publication 5 July 2016 Hester Brink, Retno Kusumaningtyas, Michel Riemersma, Joeri de Wilde Naritaweg 10 1043 BX Amsterdam The Netherlands Tel: +31-20-8208320 E-mail: [email protected] Website: www.profundo.nl Contents Samenvatting ............................................................................................................ i Summary ......................................................................................................... vii Introduction ........................................................................................................... 1 Chapter 1 Background ...................................................................................... 3 1.1 What is at stake? ....................................................................................... 3 1.2 Themes ...................................................................................................... 4 1.2.1 Organisation................................................................................................ 4 1.2.2 Policy .......................................................................................................... 7 1.2.3 Investments................................................................................................. 8 1.2.4 Reporting .................................................................................................... 9 1.2.5 Complaint mechanisms ............................................................................. 11 Chapter 2 Methodology ................................................................................... 12 2.1 Approach ................................................................................................. 12 2.1.1 Research goal ........................................................................................... 12 2.1.2 Research approach ................................................................................... 12 2.1.3 Research questions .................................................................................. 13 2.2 Scoring .................................................................................................... 16 2.2.1 Investments for the own account ............................................................... 16 2.2.2 Asset management ................................................................................... 16 2.3 Selected insurance groups .................................................................... 17 Chapter 3 Assessment of insurance groups ................................................. 18 3.1 Achmea .................................................................................................... 18 3.1.1 Company profile ........................................................................................ 18 3.1.2 Scores ....................................................................................................... 18 3.1.3 Analysis of results ..................................................................................... 23 3.1.4 Response .................................................................................................. 24 3.2 Aegon ....................................................................................................... 25 3.2.1 Company profile ........................................................................................ 25 3.2.2 Scores ....................................................................................................... 25 3.2.3 Analysis of results ..................................................................................... 31 3.2.4 Response .................................................................................................. 32 3.3 Allianz ...................................................................................................... 32 3.3.1 Company profile ........................................................................................ 32 3.3.2 Scores ....................................................................................................... 32 3.3.3 Analysis of results ..................................................................................... 38 3.3.4 Response .................................................................................................. 39 3.4 APG (Loyalis) .......................................................................................... 39 3.4.1 Company profile ........................................................................................ 39 3.4.2 Scores ....................................................................................................... 39 3.4.3 Analysis of results ..................................................................................... 44 3.4.4 Response .................................................................................................. 45 3.5 ASR .......................................................................................................... 46 3.5.1 Company profile ........................................................................................ 46 3.5.2 Scores ....................................................................................................... 46 3.5.3 Analysis of results ..................................................................................... 49 3.5.4 Response .................................................................................................. 49 3.6 Delta Lloyd............................................................................................... 49 3.6.1 Company profile ........................................................................................ 49 3.6.2 Scores ....................................................................................................... 49 3.6.3 Analysis of results ..................................................................................... 55 3.6.4 Response .................................................................................................. 56 3.7 Generali ................................................................................................... 56 3.7.1 Company profile ........................................................................................ 56 3.7.2 Scores ....................................................................................................... 56 3.7.3 Analysis of results ..................................................................................... 62 3.7.4 Response .................................................................................................. 62 3.8 Legal & General ....................................................................................... 63 3.8.1 Company profile ........................................................................................ 63 3.8.2 Scores ....................................................................................................... 63 3.8.3 Analysis of results ..................................................................................... 68 3.8.4 Response .................................................................................................. 69 3.9 NN Group ................................................................................................. 69 3.9.1 Company profile ........................................................................................ 69 3.9.2 Scores ....................................................................................................... 70 3.9.3 Analysis of results ..................................................................................... 75 3.9.4 Response .................................................................................................. 76 3.10 Vivat Verzekeringen ................................................................................ 77 3.10.1 Company profile ........................................................................................ 77 3.10.2 Scores ....................................................................................................... 77 3.10.3 Analysis of results ..................................................................................... 82 3.10.4 Response .................................................................................................. 83 Chapter 4 Conclusions and recommendations ............................................. 84 4.1 Overview of scores investments own account ..................................... 84 4.1.1 Organisation.............................................................................................. 85 4.1.2 Policy ........................................................................................................ 85 4.1.3 Investments............................................................................................... 85 4.1.4 Reporting .................................................................................................. 86 4.1.5 Complaint mechanism ............................................................................... 86 4.2 Overview of scores
Load more

Recommended publications
  • NLFI Exit Advice ASR Nederland
    Exit advice ASR Nederland NL financial investments 5 November 2015 10 15 20 25 30 35 40 45 50 55 Contents FOREWORD ...................................................................................................................................................... 3 SUMMARY & CONCLUSIONS ............................................................................................................................ 4 HISTORY PARLIAMENTARY DISCUSSION OF ASR SALE ...................................................................................... 8 5 PRECONDITIONS FOR SALE ......................................................................................................................................... 8 PARLIAMENTARY DEBATE SALES ADVICE AUGUST 2013 ................................................................................................... 8 PARLIAMENTARY DEBATE SALES ADVICE MAY 2014 ........................................................................................................ 9 SALES READINESS AND PRICE EXPECTATION .................................................................................................. 10 RESULTS ACHIEVED AND STRATEGY OF ASR ................................................................................................................. 10 10 READINESS FOR A TRANSACTION ............................................................................................................................... 11 Financial ......................................................................................................................................................
    [Show full text]
  • Online Edition 22 February 2021
    15 March, 2021 – Issue 858 penews.com Online edition 22 February 2021 The news and analysis powering European private equity The Bright Alternative in Fund and Corporate Services If you are launching a fund, looking to outsource, or are considering migrating, we can support you. Please call James Duffield, our Head of Business Development, on +44( 0)20 3818 0250 Explore: aztecgroup.co.uk | .eu Aztec Group is authorised to carry on financial services in the jurisdictions which it operates. 15 March, 2021 – Issue 858 penews.com The Bright Alternative in Fund and Corporate Services If you are launching a fund, looking to outsource, or are considering migrating, we can support you. Please call James Duffield, our Head of Business Development, on +44( 0)20 3818 0250 Explore: aztecgroup.co.uk | .eu Aztec Group is authorised to carry on financial services in the jurisdictions which it operates. www.penews.com • 15 March, 2021 News 3 CONTENTS Charterhouse to sell drugmaker Cover Cooper to CVC in €2.2bn deal Elisângela Mendonça reinvestment” in Cooper and over 35 years of activity. Its main DANILO AGUTOLI DANILO continue to support the growth targets are transactions with an London-based private equity firm and international expansion of the enterprise value of between €75m Charterhouse Capital Partners business alongside CVC, it said. and €1.5bn in services, health- said it has entered into exclusive Headquartered in Paris, Cooper care, specialised industrials and talks with CVC Capital Partners manufactures and distributes a di- consumer sectors. Since 1994, its to sell a majority stake in French versified portfolio of branded and more than 50 investments have l Michael Moore: The BVCA boss and former MP on why private equity drugmaker Cooperation Phar- basic products on an international generated €19.7bn of proceeds at must create public value maceutique Française, known as basis, to 30 export markets.
    [Show full text]
  • Press Release – 2019 Annual Results
    Press Release 12 March 2020 - Achmea Annual Results 2019 Achmea records significantly increased operational result of €547 million • Strong Non-Life result with a combined ratio of 95.0% • Sustained good Pension & Life results • Positive result current underwriting year for basic and supplementary health insurance • Strong growth in Non-Life, Retirement Services and international activities; Assets under Management grew to €200 billion at the start of 2020 • Solvency ratio robust at 214%, partly supported by financial markets • Business model expanded further with new propositions and services Willem van Duin, Chairman of the Executive Board: “As an insurer with a cooperative identity, Achmea is committed to a healthy, safe and future-proof society. We put that strategy into practice through our brands and make a difference to the lives of our customers. A sound and sustainable financial result is essential to our ability to properly fulfil our role in society. Achmea ended 2019 well with an increase of the operational result to €547 million and a solvency ratio that rose further to 214% after dividend payments. We have seen growth in both the number of customers and written premiums in property & casualty insurance, as well as a further increase in the result from our pension & life insurance activities. Our new pension services model, in which we offer a comprehensive package of asset management and banking services, is appreciated highly by our customers. The result over the 2019 underwriting year was positive for both basic and supplementary health insurance. However, the negative results on prior underwriting years caused a negative result on overall basic health insurance.
    [Show full text]
  • Premium Thresholds for Equity Options Traded at Euronext Amsterdam Premium Based Tick Size
    Premium Based Tick Size Premium thresholds for equity options traded at Euronext Amsterdam Trading Trading Premium Company symbol symbol threshold Underlying American European €0.50 €5.00 1 Aalberts AAI x 2 ABN AMRO Bank ABN x 3 Accell Group ACC x 4 Adidas ADQ x 5 Adyen (contract size 10) ADY x 6 Aegon AGN x 7 Ageas AGA x 8 Ahold Delhaize, koninklijke AH AH9 x 9 Air France-KLM AFA x 10 Akzo Nobel AKZ x 11 Allianz AZQ x 12 Altice Europe ATC x 13 AMG AMG x 14 Aperam AP x 15 Arcadis ARC x 16 ArcelorMittal MT MT9 x 17 ASM International ASM x 18 ASML Holding ASL AS9 x 19 ASR Nederland ASR x 20 BAM Groep, koninklijke BAM x 21 Basf BFQ x 22 Bayer REG BYQ x 23 Bayerische Motoren Werke BWQ x 24 BE Semiconductor Industries BES x 25 BinckBank BCK x 26 Boskalis Westminster, koninklijke BOS x 27 Brunel International BI x 28 Coca-Cola European Partners CCE x 29 CSM CSM x 30 Daimler REGISTERED SHARES DMQ x 31 Deutsche Bank DBQ x 32 Deutsche Lufthansa AG LUQ x 33 Deutsche Post REG DPQ x 34 Deutsche Telekom REG TKQ x 35 DSM, koninklijke DSM x 36 E.ON EOQ x 37 Euronext ENX x 38 Flow Traders FLW x 39 Fresenius SE & CO KGAA FSQ x 40 Fugro FUR x 41 Grandvision GVN x 42 Heijmans HEY x 43 Heineken HEI x 44 IMCD IMD x 45 Infineon Technologies NTQ x 46 ING Groep ING IN9 x 47 Intertrust ITR x 48 K+S KSQ x 49 Kiadis Pharma KDS x 50 Klépierre CIO x 51 KPN, koninklijke KPN x 52 Marel MAR x 53 Muenchener Rueckver REG MRQ x 54 NIBC Holding NIB x 55 NN Group NN x 56 NSI NSI x 57 OCI OCI x 58 Ordina ORD x 59 Pharming Group PHA x 60 Philips Electronics, koninklijke PHI
    [Show full text]
  • Webversie 2020 08 01.Xlsx
    OVERZICHT BELEGGINGSPRODUCTEN IN AEQUOTE PER 01-08-2020 OVERZICHT LIJFRENTE OPBOUW BELEGGINGSPRODUCTEN IN AEQUOTE PER 01-08-2020 Maatschappij ProductNaam Aegon Beheerd Beleggen Lijfrente Binck Pensioen Brand New Day Pensioenrekening Brand New Day ZZP Pensioenrekening Bright Pensions BrightPensioen DEGIRO Pensioenrekening Dexxi Pensioen Evi van Lanschot Evi Pensioen Leidsche verzekeringen Lijfrenteverzekering Loyalis ZZP Pensioen NNEK Pensioenrekening NNEK Pensioenrekening - Fondsenplatvorm Ostrica Perlas Rabobank Rabo ToekomstBeleggen Scildon Scildon Beleggen Scildon Nova Garant Polis Scildon Nova Polis Scildon Particulier Pensioen Plan OVERZICHT OPBOUW EIGEN WONING BELEGGINGSPRODUCTEN IN AEQUOTE PER 01-08-2020 Maatschappij ProductNaam Brand New Day Hypotheekaflossing Ostrica Perlas Rabobank Rabo OpbouwHypotheek Scildon Scildon Beleggen Scildon Nova Garant Polis Scildon Nova Polis OVERZICHT BELEGGINGSREKENINGEN IN AEQUOTE PER 01-08-2020 Maatschappij ProductNaam ABN AMRO ABN AMRO Vermogensbeheer ABN AMRO ABN AMRO Zelf Beleggen Basis ABN AMRO ABN AMRO Zelf Beleggen Plus ABN AMRO ABN AMRO Begeleid Beleggen Aegon Aegon Beheerd Beleggen Alex Vermogensbank Alex Laten beleggen ASN ASN Beleggingsrekening/Maandbeleggen ASN ASN Doelbeleggen Binck Binck Fondsbeleggen - Alles in 1 Portefeuilles Binck Binck Fondsbeleggen - Duurzaam beleggen Binck Binck Forward Binck Binck Select Binck Binck Zelf Beleggen BLG BLG Doelbeleggen Brand New Day BND Beleggingsrekening Bright Pensions Bright Beleggingsrekening Centraal Beheer Centraal Beheer Fondsbeleggen
    [Show full text]
  • A Consortium Led by APG Has Agreed to Acquire a Co-Controlling Stake In
    A Consortium led by APG has agreed to acquire a co-controlling stake in Stockholm Exergi from Fortum Helsinki, 30 June 2021 – Fortum has agreed to sell its 50% holding in Stockholm Exergi Holding AB (the “Company” or “Stockholm Exergi”) to a group of long-term European institutional investors with a strong commitment to the infrastructure sector comprising APG, PGGM, Alecta, Keva and AXA IM Alts (together, the “Consortium”). Stockholm Exergi is the owner and operator of the largest and most versatile district heating and district cooling network in the Nordics. The Company provides highly environmentally sustainable district heating for both corporate and residential customers across seven municipalities in Stockholm County, and critical electricity capacity to the Stockholm electricity grid. Anders Egelrud, CEO of Stockholm Exergi: “For the world to meet the climate change, both renewable energy and negative emissions are needed. Our goal is a climate-positive business in 2025 and to succeed in this, strong, committed, and long-term owners are required who share our view of sustainability - properties such as the City of Stockholm, Fortum and the investor consortium led by APG all share. We want to thank Fortum for their important contribution as co-owners and look forward to the next chapter in our journey towards creating the world's first climate-positive capital, together with partners, customers and owners.” Carlo Maddalena, Senior Portfolio Manager at APG, said: “The investment in Stockholm Exergi, on behalf of our pension fund client ABP, represents a significant milestone of APG’s overall commitment to significantly reduce CO2 emissions worldwide.
    [Show full text]
  • Besluit in Zaak 7051
    Openbare versie Nederlandse Mededingingsautoriteit BESLUIT Besluit van de Raad van Bestuur van de Nederlandse Mededingingsautoriteit als bedoeld in artikel 37, eerste lid, van de Mededingingswet. Nummer 7051 / 197 Betreft zaak: 7051/ Eureko B.V. - Coöperatie De Friesland U.A. I. MELDING 1. Op 15 oktober 2010 heeft de Raad van Bestuur van de Nederlandse Mededingingsautoriteit (hierna: de Raad) een melding ontvangen van een voorgenomen concentratie in de zin van artikel 34 van de Mededingingswet. Hierin is medegedeeld dat Eureko B.V. en Coöperatie De Friesland U.A. voornemens zijn een concentratie aan te gaan in de zin van artikel 27, eerste lid, van de Mededingingswet. 2. Van de melding is mededeling gedaan in Staatscourant nr. 16764 van 22 oktober 2010. Naar aanleiding van de mededeling in de Staatscourant zijn zienswijzen van derden naar voren gebracht. Deze zienswijzen worden, voor zover er overwegingen aan zijn ontleend die dragend zijn voor dit besluit, in het navolgende nader uiteengezet. Ambtshalve zijn vragen gesteld aan verschillende marktpartijen. In onderhavige zaak is een zienswijze ontvangen van de Nederlandse Zorgautoriteit (hierna: NZa); hierop wordt in de punten 54 en 55 ingegaan. II. PARTIJEN 3. Eureko B.V. (hierna: Eureko) is een besloten vennootschap naar Nederlands recht. Zij heeft als belangrijkste aandeelhouders Vereniging Achmea, die via Stichting Administratiekantoor Achmea circa 55% van de aandelen houdt en de Coöperatieve Centrale Raiffeisen-Boerenleenbank B.A. (hierna: Rabobank) die circa 39% van de aandelen houdt, terwijl de overige aandelen in handen zijn van strategische investeerders. Vereniging Achmea en Rabobank hebben gezamenlijke zeggenschap over Eureko.1 Eureko houdt alle aandelen in Achmea Holding N.V., een naamloze vennootschap naar Nederlands recht, die aan het hoofd staat van de Achmea Groep.
    [Show full text]
  • Lazard Ltd Reports Full-Year and Fourth-Quarter 2017 Results
    LAZARD LTD REPORTS FULL-YEAR AND FOURTH-QUARTER 2017 RESULTS Record annual Record annual operating Entering 2018 with record operating revenue revenue in both Asset assets under management of $2.65 billion, up 13% Management, up 20%, and and a vibrant M&A from prior year Financial Advisory, up 7% environment NEW YORK, February 1, 2018 – Lazard Ltd (NYSE: LAZ) today reported record annual operating revenue1 of $2,655 million for the year ended December 31, 2017. Net income, as adjusted1 and excluding one-time charges2, was $501 million, or $3.78 per share (diluted) for the year. Annual net income on a U.S. GAAP basis for the year was $254 million, or $1.91 per share (diluted). For the fourth quarter of 2017, net income, as adjusted1 and excluding one-time charges2, was $148 million, or $1.12 per share (diluted). On a U.S. GAAP basis, net loss for the fourth quarter was $84 million, or $0.70 per share (diluted). “Our record operating performance in 2017 underscores the strength of our business model, the power of our franchise, and the results we are achieving for clients,” said Kenneth M. Jacobs, Chairman and Chief Executive Officer of Lazard. “We have momentum in an improving global macroeconomic environment, and we continue to invest in our business to serve clients, capitalize on growth opportunities and build shareholder value.” ($ in millions, except Year Ended Quarter Ended per share data and AUM) Dec. 31, Dec. 31, 2017 2016 %’17-’16 2017 2016 %’17-’16 Net Income (loss) US GAAP $254 $388 (35)% $(84) $128 NM Per share, diluted $1.91
    [Show full text]
  • AEGON Appoints Herman Bril Senior Vice-President, Group Treasury
    The Hague, December 20, 2006 AEGON appoints Herman Bril Senior Vice-President, Group Treasury AEGON N.V. announced today that it will appoint Herman Bril (39) as Senior Vice-President for Group Treasury. In this role, he will lead AEGON's treasury and capital management activities. He will report to Michiel van Katwijk, Executive Vice-President. Herman Bril has worked for Interpolis (part of Achmea) as Managing Director, Head of Asset Management for over three years. He has been closely involved in the integration of Achmea's Pension Division over the past year. Before joining Interpolis, Herman Bril worked for FGH Bank as Treasurer and he held various positions in (investment) banking with ABN AMRO, Dresdner Bank and Deutsche Bank. Herman Bril will start with AEGON in March of next year. ABOUT AEGON AEGON is one of the world’s largest life insurance and pension companies, and a strong provider of investment products. We empower our local business units to identify and provide products and services that meet the evolving needs of our customers, using distribution channels best suited to their local markets. We take pride in balancing a local approach with the power of an expanding global operation. With headquarters in The Hague, the Netherlands, AEGON companies employ approximately 27,000 people. AEGON’s three major markets are the United States, the Netherlands and the United Kingdom. In addition, the Group is present in a number of other countries including Canada, China, Czech Republic, Hungary, Poland, Slovakia, Spain and Taiwan. Respect, quality, transparency and trust constitute AEGON’s core values as the company continually strives to meet the expectations of customers, shareholders, employees and business partners.
    [Show full text]
  • Bijlage Overzicht Investeringen in ABN AMRO En ASR (Nominaal, in € Mrd)
    Bijlage Overzicht investeringen in ABN AMRO en ASR (nominaal, in € mrd) 1 Oktober 2008 Aankoop Fortis Bank Nederland, ASR Nederland en Fortis Corporate Insurance in één koop. 16,80 2 December 2008 Het indirecte belang in ABN AMRO wordt rechtstreeks onder de Staat gebracht. Fortis Bank Nederland verkoopt dit belang aan de Staat; Staat betaalt door uitstaand vreemd vermogen kwijt te schelden. 6,54 3 Juni 2009 Verkoop van Fortis Corporate Insurance aan Amlin. -/- 0,35 4 Juli 2009, december 2009 Tweede Kamer gaat in twee fasen akkoord met de herkapitalisatie van ABN AMRO en Fortis Bank Nederland. • Aan N-share zijn converteerbare leningen van € 2,6 mrd verstrekt; vreemd vermogen zolang de N-share niet was gesepareerd, aandelenvermogen daarna. Het laatste gedeelte van de herkapitalisatie, € 0,49 mrd, zal in de vorm van aandelenkapitaal aan ABN AMRO Group beschikbaar worden gesteld. • Bij FBN is € 1,35 mrd aan vreemd vermogen omgezet in eigen vermogen. • Voor afrekening met consortiumpartners is € 0,74 mrd gereserveerd, waarvan inmiddels € 0,44 is besteed. • Wel onderdeel van de herkapitalisatie, maar geen investering is het credit relief instrument, een garantie die de Staat heeft afgegeven op een hypotheekportefeuille. Door deze garantie behoefde ABN AMRO € 1,7 mrd minder kapitaal aan te houden. Het instrument is inmiddels beëindigd. 4,88 Totale investering in ABN AMRO en ASR 27,87 5 Opbrengsten uit kapitaalverschaffing • Rente-, premie- en dividendontvangsten 2008 0,502 • Rente-, premie- en dividendontvangsten 2009 0,733 • Rente-, premie- en dividendontvangsten 2010 0,360 -/- 1,60 Netto-investering, exclusief kapitaalkosten Staat 26,27 • Per 31 december 2010 bedroeg het bij de Staat uitstaande vreemd vermogen in ABN AMRO € 4,58 mrd.
    [Show full text]
  • Bestand Oude Pensioenfondsen
    Bestand oude Pensioenfondsen Oude Naam Nieuwe Naam Aagrunol Delta Lloyd Levensverzekering N.V. Aardappelmeelindustrie en aanverwante Aegon Levensverzekering N.V. bedrijven Aarden, Pensioenfonds, F.J.M. Interpolis BTL N.V. Aarque Aegon Levensverzekering N.V. Aarque Systems B.V., Stichting Aegon Levensverzekering N.V. pensioenfonds voor het personeel van Aarts & Co Delta Lloyd Levensverzekering N.V. Abbe, de Karel I Fabrieken H. J. van Aegon Levensverzekering N.V. Aberson RVS Levensverzekering N.V. ABG AVIA, Stichting Pensioenfonds ABM Ballast Nedam, Stichting Pensioenfonds ABM II Nationale-Nederlanden Levensverzekering Maatschappij N.V. ABN AMRO P ABN Amro Bank N.V., Stichting Pensioenfonds van de ABOP Onderwijsbond, Stichting Pensioenfonds van de Algemene A.B.O.P., Stichting Onderwijsbond, Stichting Pensioenfonds van de Aanvullingspensioenfonds van de Algemene AbvaKabo, Stichting Pensioenfonds Gezondheid, Geestelijke en Maatschappelijke Belangen, Stichting Pensioenfonds voor de Accountantskantoren, Vereenigde RVS Levensverzekering N.V. Accountantsunie ZLM Avéro Pensioenverzekeringen N.V. Accountantsunie ZLM Fortis ASR Levensverzekeringen N.V. Accountantsunie ZLM, Stichting Avéro Pensioenverzekeringen N.V. Toeslagfonds Pensioenen Accountantunie ZLM, Stichting Fortis ASR Levensverzekeringen N.V. Toeslagfonds Pensioenen ACM AGRIFIRM, Stichting Pensioenfonds ACP Pensioenfonds, Stichting Douwe Egberts, Stichting Pensioenfonds Ad. Hopf Delta Lloyd Levensverzekering N.V. Adam N.V., Wormerveer Alex Gamma Holding Nederland, Stichting Pensioenfonds
    [Show full text]
  • Axa Press Release
    AXA PRESS RELEASE PARIS, 26 FEBRUARY 2016 Resolutions submitted to AXA’s Shareholders’ Meeting of April 27, 2016 AXA announces the publication of the resolutions proposed by its Board of Directors to the next Shareholders’ Meeting to be held on April 27, 2016 at 2:30 pm at the Palais des Congrès in Paris (75017) in the Bulletin des annonces légales obligatoires. In addition to an increase of the dividend (€1.10), Shareholders will be asked to approve the following principal resolutions: . Re-appointment as directors of Messrs. Stefan Lippe and François Martineau. Appointment as directors of Mrs. Irene Dorner and Mrs. Angelien Kemna. Mrs. Irene Dorner worked for nearly 30 years in the banking sector for the HSBC Group in Europe, Asia and the United States, holding several positions until 2014, including the position of President & Chief Executive Officer of HSBC USA. Mrs. Angelien Kemna worked during almost 20 years in the financial sector in the Netherlands for the Robeco and ING Groups, where she initially held the position of Global Chief Investment Officer and subsequently Chief Executive Officer for the European region before joining APG Group N.V. where she currently holds the position of Chief Finance & Risk Officer. Appointment of the director representing the employee shareholders of the AXA Group. Three candidates designated by the AXA employee shareholders will be submitted to the Shareholders’ vote. The Board of Directors has decided to recommend that the Shareholders vote in favor of the re-appointment of Mrs. Doina Palici-Chehab to serve as member of the Board of Directors.
    [Show full text]